Viewing Study NCT06973161


Ignite Creation Date: 2025-12-24 @ 1:02 PM
Ignite Modification Date: 2026-01-04 @ 3:48 PM
Study NCT ID: NCT06973161
Status: RECRUITING
Last Update Posted: 2025-12-02
First Post: 2025-04-23
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid Tumors
Sponsor: AstraZeneca
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module